Biggest News Aggregation in the World
📰 Phase News

Page 1481 - Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Phase. Real-time updates on events, politics, business and more.

Novartis Pharma AG: Novartis provides update on Phase III study evaluating canakinumab (ACZ885) as second or third-line treatment in combination with chemotherapy in non-small cell lung cancer

Novartis Pharma AG: Novartis provides update on Phase III study evaluating canakinumab (ACZ885) as second or third-line treatment in combination with chemotherapy in non-small cell lung cancer 1 non-small cell lung cancer 2,3 help 1 beta (IL-1ß) in pro-tumor inflammation i n lung cancer, with multiple clinical trials investigating canakinumab in 2 -5 Basel, March 9, 2021 - Novartis announced today the Phase III CANOPY-2 study evaluating canakinumab (ACZ885), an inhibitor of interleukin-1b...
United States Isabella Zinck Thomas Hungerbuehler Samir Shah Mary Curtin Creaser Biochim Biophys Acta

CGG : Extends Northern Viking Graben Dual-Azimuth Multi-Client Survey

Paris, France | Mar 9, 2021 CGG announced today phase two of its multi-client 3D survey in the Northern North Sea, which will expand on the phase one acquisition initiated in 2020 to add a second azimuth over CGGs existing Northern Viking Graben (NVG) multi-client 3D survey and extend coverage into the UKCS. The survey is supported by industry pre-funding. Commencing in early May and continuing throughout the North Sea season, the 2021 phase two acquisition will add approximat...
France General North Sea Oceans General Northern North Sea Northern Viking Graben Cgg Stock Exchange

Molecular Partners AG: Molecular Partners and Novartis Report Positive Initial Results from Phase 1 Study of its COVID-19 Antiviral Therapy, Ensovibep, in Healthy Volunteers

Molecular Partners AG: Molecular Partners and Novartis Report Positive Initial Results from Phase 1 Study of its COVID-19 Antiviral Therapy, Ensovibep, in Healthy Volunteers Predictable exposure seen post administration, confirming the expected half-life of 2-3 weeks Global phase 2/3 registrational study planned to initiate in Q2 2021 ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / March 9, 2021 / Molecular Partners AG (SWX: MOLN), a clinical-stage biotech company that is developing a new class...
United Kingdom Shai Biran Nicolas Leupin Seth Lewis Thomas Schneckenburger Company On Twitter At Molecularprtnrs

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Valneva : and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate

Pfizer Forward-Looking Statements The information contained in this release is as of March 8, 2021. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.  This release contains forward-looking information about a Lyme disease vaccine candidate, VLA15, and a collaboration between Pfizer and Valneva for VLA15, including their potential benefits and a potential phase 3 start, that involves su...
United States New York Kathrin Jansen Bryan Dunn Juan Carlos Jaramillo Jerica Pitts

Santiago de Cuba gets ready for third phase of vaccine candidate

Santiago de Cuba gets ready for third phase of vaccine candidate Santiago de Cuba gets ready for third phase of vaccine candidate Santiago de Cuba, Mar 8 (Prensa Latina) This city in eastern Cuba is preparing today for the third phase of clinical trials of the Abdala Covid-19 vaccine candidate, which it will share with Guantanamo, after conducting two previous ones with good results. Awaiting the approval to start that stage by the Center of State Medical Equipment and State Control of Cuba, ...
Santiago De Cuba Abdala Covid Beatriz Johnson Temas Relacionados Lazaro Exposito Biotechnology Center

Nepal PM KP Sharma Oli takes Covishield vaccine

Nepal PM KP Sharma Oli takes Covishield vaccine Top Searches Nepal PM KP Sharma Oli takes Covishield vaccine PTI / Mar 7, 2021, 16:17 IST FacebookTwitterLinkedinEMail Nepal PM KP Sharma Oli (File photo) KATMANDU: Nepal Prime Minister KP Sharma Oli took the Covishield coronavirus vaccine on Sunday, as the Himalayan nation gears up to start phase II of its immunisation drive in which all persons above 65 years will be inoculated. Oli and wife Radhika Shakya received the Covishield jabs at the T...
Pradeep Kumar Gyawali Radhika Shakya Hridayesh Tripathi Bishnu Poudel Johns Hopkins University Serum Institute Of India

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science